BACKGROUND: We recently reported that allergic lung inflammation in guinea pigs became steroid resistant in the presence of latent adenoviral infection. OBJECTIVE: We sought to investigate the molecular mechanisms that underlie steroid resistance in adenoviral infection. METHODS: Guinea pigs with a latent adenoviral infection were sensitized and challenged with ovalbumin (OVA) and given daily injections of budesonide (20 mg/kg administered intraperitoneally). Sham-infected animals received either saline challenge without budesonide injection or OVA challenge with or without budesonide. The inflammatory response in the lung was measured by means of quantitative histology. Eotaxin, monocyte chemoattractant protein 1 (MCP-1), and RANTES expression in the lung were analyzed by means of Northern blotting, and the binding activity of activator protein 1 (AP-1) and nuclear factor kappaB in nuclear extracts from the lung was analyzed with electrophoretic mobility shift assays. RESULTS: OVA challenge increased eosinophil infiltration and eotaxin and MCP-1 mRNA expression in the lungs, and glucocorticoids reduced these increases in the sham-infected, but not the adenovirus-infected, animals. Changes in binding activity of AP-1, but not nuclear factor kappaB, paralleled changes in eotaxin and MCP-1 mRNA. CONCLUSION: We conclude that latent adenoviral infection inhibits the anti-inflammatory effects of glucocorticoids on allergen-induced eotaxin and MCP-1 expression through AP-1, leading to steroid-resistant allergic lung inflammation.
BACKGROUND: We recently reported that allergic lung inflammation in guinea pigs became steroid resistant in the presence of latent adenoviral infection. OBJECTIVE: We sought to investigate the molecular mechanisms that underlie steroid resistance in adenoviral infection. METHODS:Guinea pigs with a latent adenoviral infection were sensitized and challenged with ovalbumin (OVA) and given daily injections of budesonide (20 mg/kg administered intraperitoneally). Sham-infected animals received either saline challenge without budesonide injection or OVA challenge with or without budesonide. The inflammatory response in the lung was measured by means of quantitative histology. Eotaxin, monocyte chemoattractant protein 1 (MCP-1), and RANTES expression in the lung were analyzed by means of Northern blotting, and the binding activity of activator protein 1 (AP-1) and nuclear factor kappaB in nuclear extracts from the lung was analyzed with electrophoretic mobility shift assays. RESULTS: OVA challenge increased eosinophil infiltration and eotaxin and MCP-1 mRNA expression in the lungs, and glucocorticoids reduced these increases in the sham-infected, but not the adenovirus-infected, animals. Changes in binding activity of AP-1, but not nuclear factor kappaB, paralleled changes in eotaxin and MCP-1 mRNA. CONCLUSION: We conclude that latent adenoviral infection inhibits the anti-inflammatory effects of glucocorticoids on allergen-induced eotaxin and MCP-1 expression through AP-1, leading to steroid-resistant allergic lung inflammation.
Authors: Jason B Weinberg; Gregory S Stempfle; John E Wilkinson; John G Younger; Katherine R Spindler Journal: Virology Date: 2005-09-30 Impact factor: 3.616
Authors: Gurpreet K Singhera; Tiffany S Chan; Jenny Y Cheng; Timothy Z Vitalis; Kimm J Hamann; Delbert R Dorscheid Journal: Respir Res Date: 2006-05-18
Authors: T Jartti; O Palomares; M Waris; O Tastan; R Nieminen; T Puhakka; B Rückert; A Aab; T Vuorinen; T Allander; T Vahlberg; O Ruuskanen; M Akdis; C A Akdis Journal: Allergy Date: 2014-03-29 Impact factor: 13.146
Authors: João Ferreira de Mello; Olavo de Godoy Mion; Nilvano Alves de Andrade; Wilma Terezinha Anselmo-Lima; Aldo Eden Cassol Stamm; Washingthon Luiz de Cerqueira Almeida; Pedro Oliveira Cavalcante Filho; Jair de Carvalho e Castro; Francini Grecco de Melo Padua; Fabrizio Ricci Romano; Rodrigo de Paulo Santos; Renato Roitmann; Richard Louis Voegels; Roberto Campos Meirelles; Leonardo Conrado Barbosa Sá; Moacyr Tabasnik Moacyr; Marco Cesar Jorge dos Santos; Roberto Eustáquio Santos Guimarães Journal: Braz J Otorhinolaryngol Date: 2013 May-Jun